what are the risks of glp-1 for weight loss INFOGRAPHIC: Hidden Medications How Do You Know When

A recent puff piece in the New York Times featuring Medvi, an AI-powered telehealth startup, failed to mention a litany of legal problems the company faces, including a February warning from the FDA against Medvis use of false or misleading claims about compounded GLP-1s

This phenomenon is further illustrated by results from a randomized, open-label mechanistic trial in patients with T2DM, which demonstrated that lixisenatide, with a half-life of 2 4 hours, had a significantly greater effect than liraglutide in delaying in gastric emptying and curtailing postprandial glucose excursions following a standardized solid breakfast (156)

Those folks tended to be a bit more metabolically busted

If you typically have stomach issues, start at 1 mg